Prophylactic versus restrictive platelet transfusion strategy in patients with haematological malignancies in the ICU setting, a propensity-score analysis

JB Berenger, C Saillard, A Sannini, L Servan… - Journal of Critical …, 2024 - Elsevier
Purpose Prophylactic platelet transfusions (PT) aim to reduce bleeding. We assessed
whether restrictive PT compared to prophylactic strategy could apply in ICU. Material and …

Clinical Features of Patients With Hematological Malignancies Treated at the Palliative Care Unit

H Yamane, N Ochi, A Mimura, Y Kosaka… - Palliative Medicine …, 2023 - liebertpub.com
Background: In Japan, the number of patients with aggressive hematological malignancies
(PHMs) admitted at the palliative care unit (PCU) in their end-of-life (EOL) stage was fewer …

Bloody Big Data: Ensuring the Health of Blood Donors and Transfused Patients with Health Registers

J Zhao - 2022 - search.proquest.com
Blood transfusion is widely considered a pillar of modern medicine and is one of the most
common medical interventions. A transfusion intimately links two persons and their health …

Getting the Most: Enhancing Efficacy by Promoting Erythropoiesis and Thrombopoiesis after Gene Therapy in Mice with Hurler Syndrome

J Han, SS El-Amouri, M Dai, P Cao, D Pan - Molecular Therapy-Methods & …, 2018 - cell.com
Novel strategies are needed to solve the conundrum of achieving clinical efficacy with high
vector copy numbers (VCNs) in hematopoietic stem cells (HSCs) while attempting to …

Importancia de la compatibilidad abo donante-receptor en trasplantes alogénicos de células madre hematopoyéticas para disminuir el uso de terapia transfusional …

VA Mancilla Díaz, MN Véliz Olivos - 2019 - dspace.utalca.cl
Las células madre hematopoyéticas son una población celular capaz de dar origen a todas
las células sanguíneas maduras (hematopoyesis). El trasplante alogénico de células madre …

[PDF][PDF] Thèse pour le diplôme d'état de docteur en médecine

T HÉLUAIN - 2018 - pepite-depot.univ-lille.fr
L'évaluation du dispositif de dépistage des infections sexuellement transmissibles en
maison d'arrêt «EDDISTMA*» a été mise en place dans un contexte préoccupant de …